Compare Nerdwallet Inc (NRDS) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nerdwallet Inc vs Zimmer Biomet Holdings Inc — how do they compare? Nerdwallet Inc trades at $9.41 (market cap $598.32M), while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 30.2× Nerdwallet Inc's market cap, and Zimmer Biomet Holdings Inc pays a 1.01% dividend while Nerdwallet Inc pays none. Which is the better fit depends on your goals.
| NRDS | ZBH | |
|---|---|---|
Market Cap | $598.32M | $18.05B |
Sector | Financials | Health |
52-Week High | $15.93 | $104.26 |
52-Week Low | $7.58 | $79.58 |
Enterprise Value | $512.62M | $25.11B |
Dividend Yield | — | 1.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NerdWallet (NRDS) trades at $9.56, down 3.24% today, amid a bearish technical signal. The stock shows strong fundamentals with a low P/E of 10.4 and P/S of 0.78, alongside robust revenue growth from $539M in 2022 to $837M in 2025. Recent Q2 2026 earnings missed estimates at $0.07 per share, but Q1 and Q4 2025 beat expectations. Operating cash flow improved to $132M in 2025, though net cash flow turned negative in 2026 projections.
Outlook is mixed: valuation metrics suggest upside potential, with a 66.7% analyst buy rating and a 27.9% price target upside per Zacks (August 10, 2026). However, technical weakness and Q2 earnings miss pose near-term risks. Key catalysts include continued revenue growth and margin expansion, but reliance on organic search traffic remains a headwind.
ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.
The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
